CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
InStride Health›
Library
InStride Health logo

InStride Health

InStride Health: Expert, engaging treatment for kids and teens with OCD and anxiety.

Boston, MA, US🇺🇸
Founded
2021
Loading
Overview
Compare
Fundraising
Employees
Library

InStride Health - Library

instride.health·Crawled Oct 16, 2026·

Topics

Publication type

Content origin
Row density

Blog

7 pages
  1. Preparing for School After Break/resources/back-to-school-and-beyond-navigating-nerves-and-new-beginnings-with-confidence

    A clinician and parent of two shares how to support children whose worries flare around the back-to-school transition.

  2. Procrastination and anxiety/resources/academic-avoidance-understanding-breaking-the-procrastination-cycle

    School procrastination often gets mistaken for laziness when the real driver is fear of failure or judgment. Here's how to break the cycle.

  3. Resources/resources

    The resources provide evidence-based strategies and practical tips for managing anxiety and OCD.

  4. Social media comparisons and teen anxiety/resources/the-social-media-comparison-trap-during-school-break

    When schedules slow down, scrolling fills the gap, often turning rest into a comparison spiral for teens and young adults.

Press

5 pages
  1. Female Founders 500 Names InStride Co-Founders/about-us/press/inc-names-instride-co-founders-dr-mona-potter-and-dr-kathryn-boger-to-its-2026-female-founders-500-list

    Inc.’s annual Female Founders list recognizes women entrepreneurs who collectively generated approximately $12.3 billion in 2025.

  2. First Annual Outcomes Report/about-us/press/first-annual-outcomes-report

    InStride Health, a specialty pediatric anxiety and OCD treatment provider, released its first annual outcomes report. Based on treatment of over 350 patients, InStride Health demonstrated clinically meaningful results of its coordinated care model.

  3. InStride Co-Founder and Chief Medical Officer Dr. Mona Potter recognized as one of Modern Healthcare’s 2025 Innovator Award Honorees/about-us/press/instride-co-founder-and-chief-medical-officer-dr-mona-potter-recognized-as-one-of-modern-healthcares-2025-innovator-award-honorees

    InStride Health announces that Dr. Mona Potter received Modern Healthcare’s 2025 Innovator Award, highlighting advancements in pediatric anxiety and OCD care and strong clinical outcomes.

  4. InStride Raises $30M Series C to Expand Access to Pediatric Anxiety & OCD Care/about-us/press/instride-announces-30m-in-series-c-funding

    InStride Health announced $30M in Series C funding to expand insurance-covered specialty care for young people with anxiety and OCD, building on strong growth, proven outcomes, and national expansion.

Careers & Hiring

1 page
  1. Careers/about-us/careers

    InStride Health has open roles on a team focused on improving mental health care for young people and their families.

Homepage

1 page
  1. Homepage/

    The company provides treatment for children, teens, and young adults ages 7 to 26 with anxiety, OCD, and related disorders, along with treatment for their families.